What it is
DayZero is an amniotic fluid-derived exosome preparation produced by ZEO ScientifiX, a Florida-based regenerative biologics company.
Source and manufacturing
The material is derived from human amniotic fluid and processed under controlled manufacturing standards by ZEO ScientifiX. ZEO holds patents related to its perinatal-fluid processing techniques and maintains an active clinical research portfolio in extracellular vesicle science.
How TC Regen uses it
TC Regen, exosome material is administered only by a licensed physician as part of an individualized treatment plan, following clinical evaluation at the Naples or Fort Myers location. It is offered for orthopedic and pain-related applications.
Regulatory status
Exosome products, including DayZero, are not approved by the U.S. Food and Drug Administration. No therapeutic outcome is guaranteed. A physician reviews individual risks and the written informed-consent process required under Florida law before any treatment.
Sourced from ZEO ScientifiX
MORE MATERIALS
More insights for you.
Other regenerative materials sourced and used at TC Regen.
Umbilical cord-derived stem cell material from ZEO ScientifiX, used at TC Regen under physician supervision. Not FDA-approved.
Umbilical cord-derived Wharton's Jelly Matrix from ZEO ScientifiX, used at TC Regen under physician supervision. Not FDA-approved.